SMP-114 exerts beneficial effects on both inflammation and bone destruction in arthritis model June 14, 2002
RWJ-67657 inhibits proinflammatory mediators in stimulated rheumatoid synovial fibroblasts June 14, 2002
Targeted Genetics' arthritis program discussed at ASGT meeting, heads for clinical trials June 13, 2002
Shionogi reports novel matrix metalloproteinase inhibitors and therapeutic applications thereof June 5, 2002